Korean J Gastroenterol.  2020 Jun;75(6):356-361. 10.4166/kjg.2020.75.6.356.

Metachronous Development of Peritoneal Carcinomatosis in a Patient with Autoimmune Pancreatitis

Affiliations
  • 1Departments of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 2Departments of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea

Abstract

Autoimmune pancreatitis (AIP) is a rare and unique type of chronic pancreatitis. The prognosis of AIP, particularly when associated with pancreatic cancer or a related malignancy, is not known. Only a few cases, where metachronous pancreas-related cancer developed during follow-up, have been reported. Most of these patients either underwent surgery or steroid therapy. This paper reports a case of a 66-year-old woman with untreated type I AIP who developed peritoneal carcinomatosis more than 2 years later. Initially, the patient had a markedly elevated serum IgG4 level and a diffuse, infiltrative mass-like lesion in the pancreatic head, in which the biopsy results were consistent with type I AIP. The patient was not treated with steroids because of a cerebellar infarction. Twenty-eight months after the diagnosis of AIP, peritoneal carcinomatosis developed without noticeable changes in the pancreas from the initial findings.

Keyword

Autoimmune pancreatitis; Immunoglobulin G4-related disease; Pancreatic neoplasms; Peritoneal neoplasms

Figure

  • Fig. 1 At the initial diagnosis, (A, B) computed tomography revealed the diffuse enlargement of the pancreatic head and body with peripancreatic infiltration, and (C) magnetic resonance cholangiopancreatography shows multiple strictures of the main pancreatic duct (arrow) without marked upstream dilatation. Histopathological findings of the pancreatic head showing (D) storiform fibrosis, (E) periductal lymphoplasmacytic infiltration, (F) obliterative phlebitis (D-F: H&E, ×400), and (G) positive immunoglobulin G4 staining (×400).

  • Fig. 2 Abdominal computed tomography (CT) findings at 14 months. A CT scan revealed some resolution of the peripancreatic infiltration, but there was still prominent pancreatic enlargement of the pancreatic head with a diffuse narrowing of the superior mesenteric vein and splenic vein and the collateral vessels.

  • Fig. 3 At 27 months, (A, B) abdominal computed tomography revealed no obvious change in the pancreas during follow-up, but (C) peritoneal nodularities (arrows) were identified. (D) The laparoscopy shows multiple whitish nodules on the peritoneum. (E, F) The histopathology of the nodules shows well-differentiated adenocarcinoma of a pancreaticobiliary origin (E: H&E, ×100; F: cytokeratin-7, ×200).

  • Fig. 4 Timeline of patient events. mo, months.


Reference

1. O'Reilly DA, Malde DJ, Duncan T, Rao M, Filobbos R. 2014; Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol. 5:71–81. DOI: 10.4291/wjgp.v5.i2.71. PMID: 24891978. PMCID: PMC4025075.
2. Inoue H, Miyatani H, Sawada Y, Yoshida Y. 2006; A case of pancreas cancer with autoimmune pancreatitis. Pancreas. 33:208–209. DOI: 10.1097/01.mpa.0000232329.35822.3a. PMID: 16868495.
Article
3. Witkiewicz AK, Kennedy EP, Kennyon L, Yeo CJ, Hruban RH. 2008; Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol. 39:1548–1551. DOI: 10.1016/j.humpath.2008.01.021. PMID: 18619645.
Article
4. Chandrasegaram MD, Chiam SC, Nguyen NQ, et al. 2013; A case of pancreatic cancer in the setting of autoimmune pancreatitis with nondiagnostic serum markers. Case Rep Surg. 2013:809023. DOI: 10.1155/2013/809023. PMID: 23781378. PMCID: PMC3679691.
Article
5. Ghazale A, Chari S. 2007; Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas. 35:376. DOI: 10.1097/MPA.0b013e318073ccb8. PMID: 18090248.
Article
6. Fukui T, Mitsuyama T, Takaoka M, Uchida K, Matsushita M, Okazaki K. 2008; Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med. 47:151–155. DOI: 10.2169/internalmedicine.47.0334. PMID: 18239323.
Article
7. Loos M, Esposito I, Hedderich DM, et al. 2011; Autoimmune pancreatitis complicated by carcinoma of the pancreatobiliary system:a case report and review of the literature. Pancreas. 40:151–154. DOI: 10.1097/MPA.0b013e3181f74a13. PMID: 21160372.
8. Shimosegawa T, Chari ST, Frulloni L, et al. 2011; International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 40:352–358. DOI: 10.1097/MPA.0b013e3182142fd2. PMID: 21412117.
Article
9. Kirkegård J, Mortensen FV, Cronin-Fenton D. 2017; Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am J Gastroenterol. 112:1366–1372. DOI: 10.1038/ajg.2017.218. PMID: 28762376.
Article
10. Coussens LM, Werb Z. 2002; Inflammation and cancer. Nature. 420:860–867. DOI: 10.1038/nature01322. PMID: 12490959. PMCID: PMC2803035.
Article
11. Ikeura T, Miyoshi H, Shimatani M, Uchida K, Takaoka M, Okazaki K. 2016; Long-term outcomes of autoimmune pancreatitis. World J Gastroenterol. 22:7760–7766. DOI: 10.3748/wjg.v22.i34.7760. PMID: 27678359. PMCID: PMC5016376.
Article
12. Gupta R, Khosroshahi A, Shinagare S, et al. 2013; Does autoimmune pancreatitis increase the risk of pancreatic carcinoma? : a retrospective analysis of pancreatic resections. Pancreas. 42:506–510. DOI: 10.1097/MPA.0b013e31826bef91. PMID: 23271394.
13. Hirano K, Tada M, Sasahira N, et al. 2014; Incidence of malignancies in patients with IgG4-related disease. Intern Med. 53:171–176. DOI: 10.2169/internalmedicine.53.1342. PMID: 24492683.
Article
14. Ikeura T, Miyoshi H, Uchida K, et al. 2014; Relationship between autoimmune pancreatitis and pancreatic cancer: a single-center experience. Pancreatology. 14:373–379. DOI: 10.1016/j.pan.2014.04.029. PMID: 25278307.
Article
15. Hart PA, Kamisawa T, Brugge WR, et al. 2013; Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 62:1771–1776. DOI: 10.1136/gutjnl-2012-303617. PMID: 23232048. PMCID: PMC3862979.
Article
16. Kamisawa T, Matsukawa M, Ohkawa M. 2005; Autoimmune pancreatitis associated with retroperitoneal fibrosis. Jop. 6:260–263. PMID: 15883477.
17. Fujii-Lau LL, Levy MJ. 2017; The role of endoscopic ultrasound in the diagnosis of autoimmune pancreatitis. Gastrointest Endosc Clin N Am. 27:643–655. DOI: 10.1016/j.giec.2017.06.005. PMID: 28918803.
Article
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr